Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS44015718HTLV-1ENSG00000188641.14protein_codingDPYDNoNo1806Q12882
TVIS44004704HTLV-1ENSG00000188641.14protein_codingDPYDNoNo1806Q12882
TVIS44008278HTLV-1ENSG00000188641.14protein_codingDPYDNoNo1806Q12882
TVIS44004250HTLV-1ENSG00000188641.14protein_codingDPYDNoNo1806Q12882
TVIS44003854HTLV-1ENSG00000188641.14protein_codingDPYDNoNo1806Q12882
TVIS44010773HTLV-1ENSG00000188641.14protein_codingDPYDNoNo1806Q12882
TVIS44029384HTLV-1ENSG00000188641.14protein_codingDPYDNoNo1806Q12882
TVIS44012236HTLV-1ENSG00000188641.14protein_codingDPYDNoNo1806Q12882
TVIS44033385HTLV-1ENSG00000188641.14protein_codingDPYDNoNo1806Q12882
TVIS44037259HTLV-1ENSG00000188641.14protein_codingDPYDNoNo1806Q12882
TCGA Plot Options
Drug Information
GeneDPYD
DrugBank IDDB09327
Drug NameTegafur-uracil
Target IDBE0000960
UniProt IDQ12882
Regulation Typeantagonist
PubMed IDs12950123
CitationsKim DJ, Kim TI, Suh JH, Cho YS, Shin SK, Kang JK, Kim NK, Kim WH: Oral tegafur-uracil plus folinic acid versus intravenous 5-fluorouracil plus folinic acid as adjuvant chemotherapy of colon cancer. Yonsei Med J. 2003 Aug 30;44(4):665-75. doi: 10.3349/ymj.2003.44.4.665.
GroupsApproved; Investigational
Direct ClassificationHalopyrimidines
SMILESO=C1NC=CC(=O)N1.FC1=CN(C2CCCO2)C(=O)NC1=O
Pathways
PharmGKB
ChEMBL